Ercc1 Deficiency promotes Tumorigenesis and Increases Cisplatin Sensitivity in a TP53 Context-specific Manner. Jokic M, Vlasic I, Rinneburger M, Klumper N, Spiro J, Vogel W, Offermann A, Kuempers C, Fritz C, Schmitt A, Riabinska A, Wittersheim M, Michels S, Ozretic L, Florin A, Welcker D, Akyuz MD, Nowak M, Erkel M, Wolf J, Buttner R, Schumacher B, Thomale J, Persigehl T, Maintz D, Perner S, Reinhardt HC. Journal: Mol Cancer Res. Veröffentlichung: 2016 Aug 11
